IPOs
– The ADHD treatment developer raised $27 million in its IPO in May. – Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD) raised a gross $33 million...
Hi, what are you looking for?
– The ADHD treatment developer raised $27 million in its IPO in May. – Alcobra Pharmaceuticals Ltd. (Nasdaq: ADHD) raised a gross $33 million...
– Jeremy Levin has threatened to resign because of interference by the board of directors. – Jeremy Levin – Israeli Channel 2 News reports...
– The most likely alternatives, in our view, are LNG in Cyprus, pipelines to neighboring countries (Turkey, Egypt, Jordan), or a combination, ” says...
– Arcadi Gaydamak alleges that the settlement with Lev Leviev over an Angolan diamond export venture is invalid. – ...
– 500 Startups’ Shai Goldman: It’s hard to know which companies will become big, which is why small bets on many companies is a...
– The plant will increase production capacity in the country to two billion tablets and capsules a year. – – Teva Pharmaceutical Industries Ltd. (NYSE: TEVA;...
– Marker LLC led the investment round in the energy management solutions company. – (L-R) Dr. David Almagor and Adi Shamir Panoramic Power founders –...
– The company raised $25 million in its IPO just five months ago. – – / By Gali Weinreb and Tali Tsipori /...
– Russia’s Federal Antimonopoly Service: Teva’s refusal to supply Copaxone is neither justified economically nor technologically. – Teva’s Copaxone – /By Shiri Habib-Valdhorn and...
– Facebook VP Nicola Mendelsohn: It was a momentous decision for Facebook to open its first R&D center outside the US. – ...